Your browser doesn't support javascript.
loading
Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery.
Tvedt, Tor Henrik A; Steien, Egil; Øvrebø, Bente; Haaverstad, Rune; Hobbs, William; Wardecki, Marek; Tjønnfjord, Geir Erland; Berentsen, Sigbjørn Andreas.
Affiliation
  • Tvedt THA; Department of Medicine, Haukeland University Hospital, Bergen, Norway.
  • Steien E; Department of Haematology, Oslo University Hospital and K.G. Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Øvrebø B; Department of Anesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway.
  • Haaverstad R; Department of Anesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway.
  • Hobbs W; Section of Cardiothoracic Surgery, Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.
  • Wardecki M; Sanofi, Cambridge, Massachusetts, USA.
  • Tjønnfjord GE; Sanofi, Warsaw, Poland.
  • Berentsen SA; Department of Haematology, Oslo University Hospital and K.G. Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Am J Hematol ; 97(2): E51-E54, 2022 02 01.
Article in En | MEDLINE | ID: mdl-34778998

Full text: 1 Database: MEDLINE Main subject: Complement Inactivating Agents / Antibodies, Monoclonal, Humanized / Anemia, Hemolytic, Autoimmune Limits: Aged / Humans / Male Language: En Journal: Am J Hematol Year: 2022 Type: Article Affiliation country: Norway

Full text: 1 Database: MEDLINE Main subject: Complement Inactivating Agents / Antibodies, Monoclonal, Humanized / Anemia, Hemolytic, Autoimmune Limits: Aged / Humans / Male Language: En Journal: Am J Hematol Year: 2022 Type: Article Affiliation country: Norway